Cargando…
Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk
BACKGROUND: Narcolepsy results from immune-mediated destruction of hypocretin secreting neurons in hypothalamus, however the triggers and disease mechanisms are poorly understood. Vaccine-attributable risk of narcolepsy reported so far with the AS03 adjuvanted H1N1 vaccination Pandemrix has been man...
Autores principales: | Vaarala, Outi, Vuorela, Arja, Partinen, Markku, Baumann, Marc, Freitag, Tobias L., Meri, Seppo, Saavalainen, Päivi, Jauhiainen, Matti, Soliymani, Rabah, Kirjavainen, Turkka, Olsen, Päivi, Saarenpää-Heikkilä, Outi, Rouvinen, Juha, Roivainen, Merja, Nohynek, Hanna, Jokinen, Jukka, Julkunen, Ilkka, Kilpi, Terhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266499/ https://www.ncbi.nlm.nih.gov/pubmed/25501681 http://dx.doi.org/10.1371/journal.pone.0114361 |
Ejemplares similares
-
No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix Vaccination Campaign in Finland
por: Melén, Krister, et al.
Publicado: (2013) -
AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
por: Nohynek, Hanna, et al.
Publicado: (2012) -
No evidence of autoimmunity to human OX(1) or OX(2) orexin receptors in Pandemrix-vaccinated narcoleptic children
por: Melén, Krister, et al.
Publicado: (2020) -
Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1
por: Vuorela, A., et al.
Publicado: (2021) -
Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland
por: Partinen, Markku, et al.
Publicado: (2012)